Trial Profile
Study of macular ischemia in eyes with central retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Central retinal vein occlusion
- Focus Therapeutic Use
- 30 Aug 2018 New trial record
- 01 Aug 2018 Results published in the Retina